Effects of Acute Exercise and Allopurinol Administration on Soluble Urokinase Plasminogen Activator Receptor (suPAR)

被引:11
|
作者
Sanchis-Gomar, Fabian [1 ]
Bonaguri, Chiara [2 ]
Pareja-Galeano, Helios [1 ]
Carmen Gomez-Cabrera, Mari [1 ]
Candel, Jorge [3 ]
Vina, Jose [1 ]
Lippi, Giuseppe [2 ]
机构
[1] Univ Valencia, Fdn Invest Hosp Clin Univ, Fac Med, Dept Physiol,INCLIVA, Valencia 46010, Spain
[2] Univ Parma, Azienda Osped, UO Diagnost Ematochim, Dipartimento Patol & Med Lab, I-43100 Parma, Italy
[3] Valencia CF Med Serv, Valencia, Spain
关键词
physical exercise; soluble urokinase plasminogen activator receptor; suPAR; allopurinol; EXHAUSTIVE PHYSICAL-EXERCISE; MORTALITY; TOUR;
D O I
10.7754/Clin.Lab.2012.120728
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Although physical exercise acutely increases the most widely used inflammatory biomarkers, there is no information on its effect on soluble urokinase plasminogen activating receptor (suPAR), a circulating biomarker increasingly used for the assessment of systemic inflammation. Methods: suPAR was assessed with the quantitative suPARnostic (R) Standard ELISA Assay (Virogates, Birkerod, Denmark) in 12 professional football players before and after a football match. The athletes were divided into two experimental groups. An oral dose of 300 mg of allopurinol was administered to one group of six participants four hours before a match; the other six participants received placebo. Results: Serum suPAR concentration did not vary significantly after the match in both the placebo and allopurinol group. No significant differences were observed between placebo and allopurinol groups at baseline and after the game. Conclusions: At variance with other consolidated inflammatory biomarkers, suPAR is not influenced by either physical exercise or administration of xanthine oxidase inhibitors.
引用
收藏
页码:207 / 210
页数:4
相关论文
共 50 条
  • [41] Serum Soluble Urokinase Plasminogen Activator Receptor Levels in Resistant Hypertension
    Bayrakci, Nergiz
    Ozkan, Gulsum
    Kara, Sonat Pinar
    Yilmaz, Ahsen
    Celikkol, Aliye
    TURKISH JOURNAL OF NEPHROLOGY, 2024, 33 (02): : 173 - 178
  • [42] Soluble urokinase plasminogen activator receptor measurements:: Influence of sample handling
    Riisbro, R
    Christensen, IJ
    Hogdall, C
    Brünner, N
    Hogdall, E
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2001, 16 (04) : 233 - 239
  • [43] Soluble urokinase-type plasminogen activator receptor and urokinase-type plasminogen activator receptor contribute to chemoresistance in leukemia
    Guo, Hong
    Zhou, Lan-Xia
    Ma, Haizhen
    Liu, Bei
    Cheng, Juan
    Ma, Yun-Yun
    Zhao, Li
    ONCOLOGY LETTERS, 2017, 14 (01) : 383 - 389
  • [44] Sex Differences in Circulating Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels and Adverse Outcomes in Coronary Artery Disease
    Mehta, Anurag
    Desai, Shivang R.
    Ko, Yi-An
    Liu, Chang
    Dhindsa, Devinder S.
    Nayak, Aditi
    Hooda, Ananya
    Martini, Mohamed A.
    Ejaz, Kiran
    Sperling, Laurence S.
    Reiser, Jochen
    Hayek, Salim S.
    Quyyumi, Arshed A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (05):
  • [45] Soluble urokinase Plasminogen Activator Receptor (suPAR) mediates the effect of a lower education level on adverse outcomes in patients with coronary artery disease
    Fueller, David
    Liu, Chang
    Ko, Yi-An
    Alkhoder, Ayman A.
    Desai, Shivang R.
    Almuwaqqat, Zakaria
    Patel, Shivani A.
    Ejaz, Kiran
    Kauser, Tanveer
    Martini, Mohamed Afif
    Alvi, Zain
    Mehta, Puja K.
    Sperling, Laurence S.
    Quyyumi, Arshed A.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, 31 (05) : 521 - 528
  • [46] Soluble urokinase-type plasminogen activator receptor (suPAR) is a risk indicator for eGFR loss in kidney transplant recipients
    Jehn, Ulrich
    Schuette-Nuetgen, Katharina
    Henke, Ute
    Pavenstaedt, Hermann
    Suwelack, Barbara
    Reuter, Stefan
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [47] The use of soluble urokinase plasminogen activator receptor (suPAR) as a marker of sepsis in the emergency department setting. A current review
    Velissaris, Dimitrios
    Pierrakos, Charalampos
    Karamouzos, Vasileios
    Pantzaris, Nikolas Dimitrios
    Gogos, Charalampos
    ACTA CLINICA BELGICA, 2021, 76 (01) : 79 - 84
  • [48] Plasma-soluble urokinase plasminogen activator receptor (suPAR) levels in Behcet's disease and correlation with disease activity
    Saylam Kurtipek, Gulcan
    Kesli, Recep
    Tuncez Akyurek, Fatma
    Akyurek, Fikret
    Ataseven, Arzu
    Terzi, Yuksel
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2018, 21 (04) : 866 - 870
  • [49] Soluble urokinase plasminogen activator receptor (suPAR) in bronchoalveolar fluid and blood in critically ill patients—a prospective cohort study
    Alexander C. Reisinger
    Stefan Hatzl
    Juergen Prattes
    Gerald Hackl
    Gernot Schilcher
    Florian Eisner
    Tobias Niedrist
    Reinhard Raggam
    Robert Krause
    Philipp Eller
    Infection, 2024, 52 : 249 - 252
  • [50] Soluble urokinase plasminogen activator receptor (suPAR) as a biomarker of early pregnancy location and viability compared with hCG, progesterone and estradiol
    Petersen, Jesper Friis
    Grynnerup, Anna Garcia-Alix
    Mitchell, Nikki Have
    Lossl, Kristine
    Sorensen, Steen
    Lindhard, Anette
    Friis-Hansen, Lennart
    Pinborg, Anja
    Andersen, Anders Nyboe
    Lokkegaard, Ellen
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2020, 138